<table-wrap id="T1" position="float"> 
 <label>Table 1</label>  
 <p>Results from cell and cell tumour experiments</p>  
 <table frame="hsides" rules="groups"> 
  <thead> 
   <tr> 
    <td align="left">Cell line</td>
    <td align="center">IC<sub>50 </sub>(mean &plusmn; SEM)</td>
    <td align="center" colspan="2">Tumour growth inhibition 
     <italic>
      in vivo 
     </italic>by R115777</td>
    <td align="left">Ras statusa</td>
    <td align="left">ER<sup>a</sup></td>
    <td align="left">EGFR<sup>a</sup></td>
    <td align="left">HER2<sup>a</sup></td> 
   </tr> 
   <tr> 
    <td></td>
    <td></td>
    <td colspan="2"> 
     <hr /> </td>
    <td></td>
    <td></td>
    <td></td>
    <td></td> 
   </tr> 
   <tr> 
    <td></td>
    <td></td>
    <td align="center">50 mg/kg</td>
    <td align="center">100 mg/kg</td>
    <td></td>
    <td></td>
    <td></td>
    <td></td> 
   </tr> 
  </thead> 
  <tbody> 
   <tr> 
    <td align="left">SK-BR3</td>
    <td align="center">39.0 &plusmn; 25.8 nmol/l</td>
    <td align="center">-</td>
    <td align="center">-</td>
    <td align="left">Wild-type</td>
    <td align="left">-</td>
    <td align="left">+</td>
    <td align="left">++</td> 
   </tr> 
   <tr> 
    <td align="left">MCF-7</td>
    <td align="center">46.0 &plusmn; 5.0 nmol/l</td>
    <td align="center">-</td>
    <td align="center">-</td>
    <td align="left">Wild-type, over-expression of n-ras</td>
    <td align="left">++</td>
    <td align="left">+</td>
    <td align="left">(+)</td> 
   </tr> 
   <tr> 
    <td align="left">MCF-7/HER2-18</td>
    <td align="center">60.3 &plusmn; 117 nmol/l</td>
    <td align="center">80.8%</td>
    <td align="center">95.9%</td>
    <td align="left">Wild-type, over-expression of n-ras</td>
    <td align="left">++</td>
    <td align="left">+</td>
    <td align="left">+++</td> 
   </tr> 
   <tr> 
    <td align="left">BT474</td>
    <td align="center">195 &plusmn; 119 nmol/l</td>
    <td align="center">-</td>
    <td align="center">-</td>
    <td align="left">Wild-type</td>
    <td align="left">+</td>
    <td align="left">-</td>
    <td align="left">++</td> 
   </tr> 
   <tr> 
    <td align="left">SKOV3</td>
    <td align="center">2.7 &plusmn; 0.4 μmol/l</td>
    <td align="center">60.1%</td>
    <td align="center">20.4%</td>
    <td align="left">Wild-type</td>
    <td align="left">-</td>
    <td align="left">++</td>
    <td align="left">+++</td> 
   </tr> 
   <tr> 
    <td align="left">MDA-MB231</td>
    <td align="center">5.9 &plusmn; 0.8 μmol/l</td>
    <td align="center">-68.8%</td>
    <td align="center">-91.2%</td>
    <td align="left">Mutated k-ras</td>
    <td align="left">-</td>
    <td align="left">+++</td>
    <td align="left">+</td> 
   </tr> 
  </tbody> 
 </table> 
 <table-wrap-foot> 
  <p>The table shows the concentration of R115777 required to reduce cell numbers by 50% (50% inhibitory concentration [IC<sub>50</sub>]), inhibition by R115777 at two different doses in tumours grown in athymic mice, and receptor and ras status for the different cancer cell lines. <sup>a</sup>Data collected from the literature [4,12,46]. EGFR, epidermal growth factor receptor; ER, oestrogen receptor; SEM, standard error of the mean.</p> 
 </table-wrap-foot> 
</table-wrap>